Vital Farms stock surged 10.5% after reports of a potential sale surfaced, with Jefferies maintaining a buy rating and $15 price target despite recent margin pressures.
Shares rallied on report of a potential sale or take-private at $15-$25 per share, and Jefferies reiterated its buy rating with a $15 price target, suggesting upside.
Vital Farms shares rallied Thursday following reports that the pasture-raised egg producer is exploring strategic options, including a potential sale or take-private deal. The company is reportedly targeting a valuation between $15 and $25 per share as it navigates recent profitability headwinds and industry oversupply.
The company is evaluating options, including a sale, following a challenging second quarter marked by industry oversupply, unfavorable sales mix, and profitability pressures.
Jefferies maintains a buy rating with a $15 price target, suggesting that the company's Q2 performance represented the peak of its recent operational difficulties.